Your browser doesn't support javascript.
loading
Which lipid measurement should we monitor? An analysis of the LIPID study.
Glasziou, Paul P; Irwig, Les; Kirby, Adrienne C; Tonkin, Andrew M; Simes, R John.
Affiliation
  • Glasziou PP; Centre for Research in Evidence-Based Practice, Bond University, Gold Coast, Queensland, Australia.
BMJ Open ; 4(2): e003512, 2014 Feb 21.
Article in En | MEDLINE | ID: mdl-24561494
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mass Screening / Pravastatin / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Acute Coronary Syndrome / Hyperlipidemias / Lipids Type of study: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa / Oceania Language: En Journal: BMJ Open Year: 2014 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mass Screening / Pravastatin / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Acute Coronary Syndrome / Hyperlipidemias / Lipids Type of study: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa / Oceania Language: En Journal: BMJ Open Year: 2014 Document type: Article Affiliation country: